Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Aug 19, 2025 | Sale | $3.00 | 588 | 1,762 | 135,462 | Aug 20, 2025, 05:00 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Aug 18, 2025 | Sale | $3.07 | 1,004 | 3,077 | 136,050 | Aug 20, 2025, 05:00 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Aug 14, 2025 | Sale | $3.02 | 12,109 | 36,557 | 137,054 | Aug 18, 2025, 04:35 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | May 20, 2025 | Sale | $6.45 | 587 | 3,784 | 149,163 | May 22, 2025, 04:05 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | May 16, 2025 | Sale | $6.53 | 946 | 6,175 | 149,750 | May 20, 2025, 04:05 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Feb 21, 2025 | Sale | $10.58 | 3,222 | 34,089 | 150,696 | Feb 25, 2025, 04:01 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Nov 21, 2024 | Sale | $13.05 | 1,175 | 15,338 | 63,560 | Nov 25, 2024, 04:05 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Aug 16, 2024 | Sale | $18.50 | 1,027 | 19,004 | 64,735 | Aug 20, 2024, 04:26 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | May 14, 2024 | Option/RSU Exercise | - | 2,420 | - | 21,100 | May 20, 2024, 04:29 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | May 16, 2024 | Sale | $23.35 | 1,048 | 24,471 | 65,762 | May 20, 2024, 04:29 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Feb 29, 2024 | Sale | $29.33 | 4,100 | 120,257 | 18,680 | Mar 04, 2024, 06:48 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Feb 16, 2024 | Sale | $29.84 | 3,576 | 106,701 | 6,136 | Feb 21, 2024, 08:54 PM | |
RCKT | ROCKET PHARMACEUTICALS, INC. | Martin Wilson | General Counsel | Feb 14, 2024 | Option/RSU Exercise | - | 9,712 | - | 9,712 | Feb 16, 2024, 04:05 PM |